IBX ASX · Health Care

Imagion Biosystems Ltd

Announcements, last 12 months: 67
Price sensitive, last 12 months: 16
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
8 Oct 2026, 9:19 AM	Appendix 4C and Quarterly Activities Report - September 2026 Price sensitive	AI summary
30 Sep 2026, 9:57 AM	IBX Secures Central Ethics Approval - Key Phase 2 Milestone Price sensitive	AI summary
14 Sep 2026, 9:03 AM	MagSense Nanoparticle Manufacturing Update Price sensitive	AI summary
4 Sep 2026, 9:26 AM	IBX Investor Presentation
1 Sep 2026, 10:06 AM	Cleansing Notice
1 Sep 2026, 10:04 AM	Application for quotation of securities - IBX
1 Sep 2026, 9:59 AM	Application for quotation of securities - IBX
27 Aug 2026, 10:18 AM	Notification of cessation of securities - IBX
26 Aug 2026, 9:47 AM	IBX Phase 2 Clinical Trial Update Price sensitive	AI summary
25 Aug 2026, 3:40 PM	Change of Director's Interest Notices - RP, BM, NW

Sign in to see all IBX announcements.

Guidance history

24 Aug 2026	Loss from ordinary activities after tax: $1,981,169 (half-year 2026)
31 Jul 2026	Imagion Biosystems expects higher operating cash outflows in the next quarter due to clinical study initiation costs.
27 Feb 2026	The Consolidated Entity expects to maintain general and administration costs at a similar level as at the end of 2025 for the foreseeable future.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow IBX to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.